Mulligan Seamus

Avg. Two Year Performance

< 1% Avg. Purchase Return
0% Compound
(84%) Avg. Sale Return
(36%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)(3%)10%(2%)< 1%
Purchase Success Rate0 of 21 of 21 of 20 of 21 of 2
Average Sale Return5%6%(2%)(22%)(84%)
Sale Success Rate9 of 115 of 113 of 115 of 116 of 11
Drugs » Biotechnology

Director:

Holdings: 601.73K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 1.18M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--